đź“‹ FDA Reference
lyophilized multiblast medium kit
Irvine Scientific Sales
Summary: The Lyophilized Multiblast Medium Kit is used in embolization procedures to occlude blood vessels. It is primarily utilized by interventional radiologists in various clinical settings.
FDA Clearance Information
Pathway
510K
Number
K072608 ↗
Decision Date
January 30, 2008
Product Code
MQL
Device Class
Class 2
Evidence
419 studies
The Lyophilized Multiblast Medium Kit was cleared through the FDA 510(k) pathway on January 30, 2008. Manufactured by Irvine Scientific Sales, it is a Class 2 medical device.
What It Is
The Lyophilized Multiblast Medium Kit is a medical device used in embolization procedures, which involve the intentional blockage of blood vessels. It consists of a lyophilized medium that, when reconstituted, can be injected into the vasculature to occlude blood flow. This technique is often employed to treat conditions such as arteriovenous malformations or to reduce blood supply to tumors.
Clinical Applications
This device is commonly used in interventional radiology, particularly for embolization procedures. It is utilized in hospitals and specialized clinics to manage conditions like uterine fibroids, liver tumors, and gastrointestinal bleeding. The patient population includes individuals with vascular abnormalities or tumors requiring reduced blood supply.
Indications for Use
The FDA-cleared indications for this device involve its use in embolization procedures to occlude blood vessels. It is suitable for patients with conditions that benefit from reduced blood flow, such as certain tumors or vascular malformations.
Practical Considerations
Clinicians should ensure compatibility with existing catheter systems when using the Lyophilized Multiblast Medium Kit. The reconstitution process should be performed according to the manufacturer's instructions to ensure optimal performance during procedures.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is the Lyophilized Multiblast Medium Kit used for?
It is used for embolization procedures to occlude blood vessels in various medical conditions.
What specialties typically use this device?
Interventional radiologists primarily use this device in hospital and clinical settings.
What are the FDA-cleared indications?
The device is indicated for use in embolization procedures to occlude blood vessels, suitable for conditions like tumors or vascular malformations.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.